Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M688Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M-12.7EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)18.7Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.3PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M5,396,503ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with BBH

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

BBH is held by these investors:



BBH: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rapps, MichaelDirector, Director or Senior Officer of 10% Securi 2017-01-16Buy1,200$9.481231.86view
Gridley, Anthony RonaldSenior Officer 2017-01-16Sell1,800$16.94645.34view
Dinwoodie, Tyler Wayne PaulSenior Officer 2017-01-16Buy4,000$0.1774170.59view
Brown, Mark ThomasDirector 2017-01-16Sell29,300$1.369183.82view
Bebek, IvanDirector 2017-01-16Buy8,990$3.383635.5view
smith, laurie james10% Security Holder, Director, Senior Officer 2017-01-16Buy7,500$0.4130695.12view
MEHR, JEFFREYSenior Officer 2017-01-13Sell50,000$27.91352.38view
Squibb, Geoffrey WayneDirector 2017-01-13Buy267$6.271913.72view
Smith, DavidSenior Officer 2017-01-13Sell15,000$60.38109.11view
Rowlands, William BruceDirector, Senior Officer 2017-01-13Buy20,000$0.1584073.33view

Quarterly/Annual Reports about BBH:

    News about BBH:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Too Late To Catch Biotech Rally As Trump Fears Subside? Jun 23 2017
    5 Reasons Why Biotech ETFs are Soaring Jun 22 2017
    Investor Update: Incyte’s Key Developments in 1Q17 Jun 16 2017
    Developments for Ionis Pharmaceuticals after 1Q17 Jun 13 2017
    Biotech Stocks Feel the Pain: Time to Buy? May 31 2017
    Why Biotech Stocks Are Hitting the Skids May 15 2017
    [$$] How to Pick a Health-Care ETF May 13 2017
    Biotech ETFs Sink After House Passage of Health-Care Bill May 11 2017
    ETF Floppers: Trail Mix May 10 2017
    Inside Allergan’s 1Q17 Results: Revenue Streams May 10 2017
    Gilead Sciences Posts Mixed Q1 Results: ETFs in Focus May 03 2017
    Are Q1 ETF Toppers Healthy Enough for Further Run in Q2? Apr 07 2017
    Time to Buy Biotech ETF? Mar 13 2017
    Demand offers big opportunity in health care stocks: Pro Mar 08 2017
    Healthcare ETFs in Focus on Obamacare Replacement Plan Mar 07 2017
    Trump's Immigration Plans an Overhang on Biotech ETFs? Mar 02 2017
    Biotech ETF (BBH) Hits New 52-Week High Mar 02 2017
    Biotech ETFs Powered by Q4 Earnings Feb 10 2017
    What Lies Ahead for Biotech ETFs in Trump Era? Jan 27 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat

    {{numOfNotice}}